Skip to main content
Premium Trial:

Request an Annual Quote

Genetic Technologies Lab Gets Regulatory Approvals in US, Australia

NEW YORK — Genetic Technologies said on Tuesday that its lab has received regulatory approvals in Australia and the US that will enable the commercial launch of its GeneType risk-assessment test for certain cancers and other diseases in those markets.

The test is designed to analyze an individual's personal clinical, family, and genetic data to determine their likelihood of developing breast, colorectal, prostate, and ovarian cancers, as well as coronary artery disease and type 2 diabetes.

The Melbourne, Australia-based company said that its lab has recently received accreditation from Australia's National Association of Testing Authorities and CLIA certification from the US Centers for Medicare & Medicaid Services, clearing the way for a commercial release of the test for healthcare professionals in the two countries this week.

"There is a substantial market opportunity for this [test], and we are excited to leverage our expanded sales and marketing platform to bring this product to market," Genetic Technologies CEO Simon Morriss said in a statement. "This test will provide a proactive assessment test for patients and clinicians with the aim to improve patient outcomes in the long term."

In September, Genetic Technologies partnered with Washington University's Institute for Public Health on a study designed to expand the predictive capability of its GeneType for breast cancer in women of African descent.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.